Introduction
Fat embolism syndrome (FES) resulting from extensive bone marrow necrosis (BMN) is a rare but potentially underdiagnosed and probably the most devastating acute complication of sickle-cell disease (SCD). It is characterized by acute respiratory failure, neurological manifestations, thrombocytopenia, and involvement of various other organs and systems. The peripheral blood smear shows a leukoerythroblastic picture with a striking number of circulating nucleated red blood cells (NRBCs), whereas biochemical analysis shows extremely high levels of serum ferritin (SF) and lactic dehydrogenase (LDH) [1] . In the largest to date systematic review of the literature, 58 cases were identified. Only 19% of patients had sickle-cell anemia (HbSS) whereas the remainder had other genotypes, mostly HbSC and HbSb+ that are usually associated with milder disease. In addition, lack of serious previous sickle-related complications and an overall milder phenotype were evident for the majority of cases with 33% having undiagnosed SCD until they developed FES. Mortality in the reported cases was 29, 61, and 91% for patients receiving exchange, top-up, or no transfusion, respectively. A possible association with human parvovirus B19 (HPVB19) was also identified [2] . Here, we present three consecutive cases of FES in SCD presenting over the course of 12 months treated successfully with intensive exchange transfusion. The diagnosis of FES was made according to the following published definitions: FES was defined as multi-or single organ histologically proven involvement by fat and/or necrotic marrow emboli or development of acute respiratory distress and neurological manifestations or multiorgan failure with evidence of BMN (pathological proof or laboratory evidence). BMN was defined as histologically proven (autopsy or biopsy) extensive BMN or a relevant clinicopathological picture in the context of FES; that is the rapid development of anemia and thrombocytopenia This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
with a leukoerythroblastic peripheral smear with high numbers of circulating NRBCs [2] .
Cases
We present here three cases of FES in SCD. All three patients provided their written consent. The first patient was a 29-year-old man with hitherto mild HbSC disease. He was known to have avascular necrosis (AVN) of the left shoulder but no other sickle-related complications and no history of hospitalization since childhood. He was admitted with lower limb pain of extreme and unusual severity and was treated with parenteral opiate analgesia and fluids. There were no obvious precipitating factors for his crisis, and he only gave a history of a "flu-like" illness while visiting Amsterdam 2 weeks before this presentation. His vital signs at presentation were stable, and his baseline hematological and biochemical investigations are summarized in Table 1 . However, within the first 48 h of presentation, he deteriorated rapidly developing respiratory failure and bilateral pulmonary infiltrates on the chest radiograph. A diagnosis of acute chest syndrome (ACS) was made, and he was transferred to the intensive care unit (ICU) for noninvasive ventilation (NIV). He was commenced on broad spectrum antibacterials, and an emergency manual partial exchange transfusion was undertaken achieving a posttransfusion HbS level of 34%. A few hours later, he became suddenly comatose and required intubation. An urgent CT head was reported as normal. Antivirals were added to his treatment, and he was further exchanged to an HbS of 22%. In the following 72 h, he developed progressive pancytopenia with a leukoerythroblastic picture on the peripheral blood smear and a striking number of circulating nucleated red cells. No bacteria or viruses were detected in his blood, or cerebrospinal fluid except for HPVB19 that was detected by serology (IgM+/IgG-) and polymerase chain reaction (PCR). An MRI brain showed multiple widespread microhemorrhages consistent with cerebral fat emboli ( Fig. 1) , and based on the clinical, hematological, and radiological features, a unifying diagnosis of FES was made. He remained in ICU with reduced Glasgow coma scale for a month, but then started making a gradual but slow neurological recovery. He was discharged after prolonged inpatient neuro-rehabilitation, 1 year after the original admission, substantially improved, independently mobile but with some residual cognitive impairment. He was initially treated with regular automated red cell exchange transfusion (ARCET) for a year (until he declined it) but continues to take hydroxycarbamide.
The second patient, a 26-year-old man, with previously uncomplicated HbSC disease, and no previous hospital admissions presented with 24 h of severe abdominal pain Table 1 . Evolution of hematological and biochemical parameters for patients 1, 2, and 3.
Hb (g/L)
PLT (x10 (7) 107 (1) 45 (1) 37 (5) 66 (3) 37 (4) The third patient was a 40-year-old woman with HbSS and mild previous disease with very infrequent hospital visits and no evidence of other end organ damage except for severe AVN of hips and shoulders. She was admitted with a 3-day history of fever, rigors, and dysuria and few hours of severe lower back and upper and lower limb pain. On admission, her temperature was 37.8°C, her oxygen saturation (SaO 2 ) 100% breathing room air, and her chest radiograph unremarkable. She was treated with parenteral opiate analgesia, broad spectrum antibacterials, and fluids. On d2 of admission, she deteriorated suddenly with development of type I respiratory failure with extensive bilateral infiltrates on chest radiograph, altered mental status, and pancytopenia ( Table 1 ). The peripheral blood smear showed a leukoerythroblastic picture with 36% nucleated red cells/100 circulating nucleated cells. Given the clinical and hematological picture, a diagnosis Figure 1 . T2* weighted gradient echo images through the head reveal numerous small hypointense lesions (arrows) throughout the brain due to susceptibility artifact from hemosiderin deposition. These lesions predominantly lie in the corpus callosum and periventricular and subcortical regions. of FES due to BMN was made. She was transferred to ICU and underwent emergency ARCET to an HbS of 6.9%. This led to significant improvement of her respiratory function and mental status, but her cytopenias as well as her liver function tests continued to deteriorate and she also developed renal impairment (creatinine 136 lmol/L). Bone marrow biopsy performed on d4 confirmed extensive bone marrow necrosis (Fig. 2) . E.Coli was isolated from her blood, and urine. Testing for HPV B19 was not undertaken. Due to her deteriorating liver function, she was transferred to a specialist liver unit on d5. Without any further intervention there, her liver function gradually improved and was discharged 2 weeks after the transfer. She made a full recovery and is on no longterm treatment.
Discussion FES is a rare and devastating complication of SCD. It is mostly associated with nonhomozygous SCD and disease of a previously milder clinical phenotype. Several hypotheses have been put forward to explain this association including the higher hematocrit in HbSC compared to HbSS patients and the resulting higher blood viscosity [3] and HPV B19 induced endothelitis resulting in increased vascular adhesion and infarction in patients with high baseline hemoglobin [4] whereas we have previously suggested an immune-mediated mechanism in these patients who unlike HbSS patients may retain some splenic function [2] .
FES is potentially underdiagnosed: Its association with milder forms of SCD may lead to late diagnosis or underrecognition. Several reports have previously identified rates of unexplained or "sudden" death as high as 40% occurring in relatively healthy patients during a painful crisis [5] [6] [7] while an autopsy study showed that pulmonary fat emboli were present in one-third of cases of "sudden death" in SCD [8] . Moreover, some cases of "multiorgan failure syndrome" a well-recognized but poorly understood in its pathophysiology entity also affecting previously well patients presenting with a seemingly uncomplicated painful crisis and deteriorating rapidly [9] may indeed represent cases of FES.
Given the respiratory and neurological manifestations, the syndrome can be mistaken for isolated ACS or stroke whereas the combination of fever, neurological manifestations, and thrombocytopenia may suggest a diagnosis of thrombotic thrombocytopaenic purpura [10] or even acute leukemia if the cytopaenias are severe. Examination of the peripheral blood smear is essential, and our current practice is to also obtain a bone marrow sample.
Despite the rarity of the syndrome, these three cases presented within 1 year; such experience has previously been reported where three patients with FES were identified and treated in a single institution within a sevenmonth period [10] . Such skewing of cases may reflect heightened physicians' awareness after treating a case but may also be related to periodic epidemics of viruses such as HPVB19 that has been reported to be associated with FES [11, 12] .
Two of the three patients we present had HbSC disease, and all three had a previous mild course of their illness. Their presentation highlights the importance of being highly vigilant when previously well patients present with unusually severe crises and their outcome illustrates the importance of prompt recognition of FES, adequate supportive care, and easy access to ICU and more importantly, the potential success of early intensive exchange transfusion targeting marked reduction in HbS levels. Given the relative safety of the procedure in the context of a life-threatening illness and its fulminant course, our policy is to institute ARCET as soon as FES is suspected. Despite rapid deterioration, multiple organ impairment and requirement for intensive care support, all patients survived, two without any residual deficit.
